Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Waldron

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
The Journal of Physiology|May 4, 2019
The Orai Ca<sup>2+</sup> channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitisRichard T Waldron, Yafeng Chen, Hung Pham, et al.
Journal of Medicinal Chemistry|August 24, 2000
Biphenylsulfonamide endothelin receptor antagonists. 2. Discovery of 4'-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ET(A) antagonistsN Murugesan, Z Gu, P D Stein, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 10, 2019
Simvastatin induces autophagic flux to restore cerulein-impaired phagosome-lysosome fusion in acute pancreatitisHonit Piplani, Stefanie Marek-Iannucci, Jon Sin, et al.
The American Journal of Pathology|September 23, 2017
Human Pancreatic Acinar Cells: Proteomic Characterization, Physiologic Responses, and Organellar Disorders in ex Vivo PancreatitisAurelia Lugea, Richard T Waldron, Olga A Mareninova, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 9, 2021
Biomarkers of Chronic Pancreatitis: A systematic literature reviewZobeida Cruz-Monserrate, Kristyn Gumpper, Valentina Pita, et al.
Alcohol, Clinical & Experimental Research|March 20, 2025
Differential impact of recent heavy drinking on first and recurrent acute pancreatitisChristie Y Jeon, Yu Ye, Georgios I Papachristou, et al.
Pancreas|November 17, 2022
Salivary Biomarker Evaluation of Chronic Pancreatitis Patients Reveals Alterations in Human Proteins, Cytokines, Prostaglandin E2 Levels, and Bacterial DiversityRichard T Waldron, Elaina K Jones, Vincent I Anani, et al.
Pancreas|February 23, 2022
A Randomized, Double-Blinded, Placebo-Controlled Trial of Simvastatin to Prevent Recurrent PancreatitisMarc T Goodman, Simon K Lo, Dhiraj Yadav, et al.
Plos One|September 9, 2017
Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D miceHui-Hua Chang, Aune Moro, Kazuki Takakura, et al.
Journal of Medicinal Chemistry|December 19, 1998
Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308)N Murugesan, Z Gu, P D Stein, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
The Journal of Physiology|May 4, 2019
The Orai Ca<sup>2+</sup> channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitisRichard T Waldron, Yafeng Chen, Hung Pham, et al.
Journal of Medicinal Chemistry|August 24, 2000
Biphenylsulfonamide endothelin receptor antagonists. 2. Discovery of 4'-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ET(A) antagonistsN Murugesan, Z Gu, P D Stein, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 10, 2019
Simvastatin induces autophagic flux to restore cerulein-impaired phagosome-lysosome fusion in acute pancreatitisHonit Piplani, Stefanie Marek-Iannucci, Jon Sin, et al.
The American Journal of Pathology|September 23, 2017
Human Pancreatic Acinar Cells: Proteomic Characterization, Physiologic Responses, and Organellar Disorders in ex Vivo PancreatitisAurelia Lugea, Richard T Waldron, Olga A Mareninova, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 9, 2021
Biomarkers of Chronic Pancreatitis: A systematic literature reviewZobeida Cruz-Monserrate, Kristyn Gumpper, Valentina Pita, et al.
Alcohol, Clinical & Experimental Research|March 20, 2025
Differential impact of recent heavy drinking on first and recurrent acute pancreatitisChristie Y Jeon, Yu Ye, Georgios I Papachristou, et al.
Pancreas|November 17, 2022
Salivary Biomarker Evaluation of Chronic Pancreatitis Patients Reveals Alterations in Human Proteins, Cytokines, Prostaglandin E2 Levels, and Bacterial DiversityRichard T Waldron, Elaina K Jones, Vincent I Anani, et al.
Pancreas|February 23, 2022
A Randomized, Double-Blinded, Placebo-Controlled Trial of Simvastatin to Prevent Recurrent PancreatitisMarc T Goodman, Simon K Lo, Dhiraj Yadav, et al.
Plos One|September 9, 2017
Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D miceHui-Hua Chang, Aune Moro, Kazuki Takakura, et al.
Journal of Medicinal Chemistry|December 19, 1998
Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308)N Murugesan, Z Gu, P D Stein, et al.
Pageof 10